Publications
Found 5 results
Filters: Author is R. Vasudevan [Clear All Filters]
“Analysis of selected glutathione S-transferase gene polymorphisms in Malaysian type 2 diabetes mellitus patients with and without cardiovascular disease”, vol. 15, p. -, 2016.
, , , “Association of beta 2 adrenoceptor gene polymorphisms in Malaysian hypertensive subjects”, vol. 13, pp. 2939-2948, 2014.
, “Association of variable number of tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in Malaysian patients”, vol. 10, pp. 943-947, 2011.
, 16th Report of the Malaysian Dialysis & Transplant Registry (2008).The National Renal Registry. Malaysian Society of Nephrology, Kuala Lumpur.
Freedman BI, Yu H, Spray BJ, Rich SS, et al. (1997). Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int. 51: 819-825. Doi: 10.1038/ki.1997.115.
doi:10.1038/ki.1997.115
PMid:9067916
Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, et al. (2004). Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin. Exp. Immunol. 138: 145-150. Doi: 10.1111/j.1365-2249.2004.02590.x.
doi:10.1111/j.1365-2249.2004.02590.x
PMid:15373917 PMCid:1809180
Kirchheiner J, Grundemann D and Schomig E (2006). Contribution of allelic variations in transporters to the phenotype of drug response. J. Psychopharmacol. 20: 27-32. Doi: 10.1177/1359786806066043.
doi:10.1177/1359786806066043
PMid:16785267
Konwar R and Bid HK (2008). Location of the 70bp VNTR polymorphic site is in third intron of IL-4 gene. Ind. J. Clin. Biochem. 23: 204-205. Doi: 10.1007/s12291-008-0046-y.
doi:10.1007/s12291-008-0046-y
Masutani K, Miyake K, Nakashima H, Hirano T, et al. (2003). Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am. J. Kidney Dis. 41: 371-379. Doi: 10.1053/ajkd.2003.50046.
doi:10.1053/ajkd.2003.50046
PMid:12552499
Mittal RD and Manchanda PK (2007). Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics 59: 159-165. Doi: 10.1007/s00251-006-0182-6.
doi:10.1007/s00251-006-0182-6
PMid:17203290
Nakashima H, Miyake K, Inoue Y, Shimizu S, et al. (2002). Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 3: 107-109. Doi: 10.1038/sj/gene/6363830.
doi:10.1038/sj.gene.6363830
PMid:11960309
Nordfors L, Lindholm B and Stenvinkel P (2005). End-stage renal disease-not an equal opportunity disease: the role of genetic polymorphisms. J. Intern. Med. 258: 1-12.
doi:10.1111/j.1365-2796.2005.01516.x
PMid:15953127
Persu A (2006). Candidate gene studies: accepting negative results. J. Hypertens. 24: 443-445. Doi: 10.1097/01. hjh.0000209978.98240.e5.
Tripathi G, Dharmani P, Khan F, Sharma RK, et al. (2006). High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMC Nephrol. 7: 15.
doi:10.1186/1471-2369-7-15
PMid:17042963 PMCid:1626448
Tripathi G, Sharma RK, Baburaj Pv, Sankhwar NS, et al. (2008). Genetic risk factor for renal failure among North Indian ESRD patients. Clin. Biochem. 41: 525-531.
doi:10.1016/j.clinbiochem.2008.01.009
PMid:18242170
Tsai FJ, Chang CH, Chen CC, Hsia TC, et al. (2005). Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder. BJU Int. 95: 432-435.
doi:10.1111/j.1464-410X.2005.05315.x
PMid:15679809
Wetmore JB, Hung AM, Lovett DH, Sen S, et al. (2005). Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int. 68: 278-284. Doi: 10.1111/j.1523-1755.2005.00403.x.
doi:10.1111/j.1523-1755.2005.00403.x
PMid:15954918
Wu MC, Huang CM, Tsai JJ, Chen HY, et al. (2003). Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan. Lupus 12: 21-25. Doi: 10.1191/0961203303lu249oa.
doi:10.1191/0961203303lu249oa
PMid:12587822
Yao Q, Lindholm B and Stenvinkel P (2004). Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial. Int. 8: 118-129.
doi:10.1111/j.1492-7535.2004.01085.x
PMid:19379407